Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Clinical Outcomes of Acquired Factor VIII Inhibitors in Cancer Population: A Systematic Review

Heidi Chwan Ko, DO, Cristhiam Rojas Hernandez, MD, Thein Hlaing Oo, MD

Blood (2017) 130 (Supplement 1): 5639.

https://doi.org/10.1182/blood.V130.Suppl_1.5639.5639

Published: 2017

Journal Articles

Characterization of an autosomal dominant bleeding disorder caused by a thrombomodulin mutation

Yesim Dargaud, Jean Yves Scoazec, Simone J. H. Wielders, Christine Trzeciak, Tilman M. Hackeng, Claude Négrier, H. Coenraad Hemker, Theo Lindhout, Elisabetta Castoldi

Blood (2015) 125 (9): 1497–1501.

https://doi.org/10.1182/blood-2014-10-604553

Published: 2015

Journal Articles

Inherited Pro-Thrombotic Risk Factors in Children of South Moravia Region, Czech Republic

Ondrej Zapletal, MD, Jan Blatny, MD, PhD, Eva Janousova, PhD

Blood (2012) 120 (21): 5136.

https://doi.org/10.1182/blood.V120.21.5136.5136

Published: 2012

Journal Articles

Barriers to the Effective Diagnosis and Management of a Bleeding Patient with Undiagnosed Bleeding Disorder Across Multiple Specialties: Results of a Quantitative Case-Based Survey.

Mark T. Reding, MD, David L. Cooper, MD, MBA

Blood (2010) 116 (21): 3673.

https://doi.org/10.1182/blood.V116.21.3673.3673

Published: 2010

Journal Articles

Thrombophilia as a Risk Factor for Central Retinal Vein Thrombosis.

Fotios I Girtovitis, Elisabet Tsakiroglou, Michael D. Diamantidis, Zoi Saouli, Zisis Kontoninas, Virginia Voulgaridou, Ilias Merakis, Georgia Kaiafa, Athanasios Papadopoulos Sr.

Blood (2009) 114 (22): 5054.

https://doi.org/10.1182/blood.V114.22.5054.5054

Published: 2009

Journal Articles

Adherence to Transfusion Protocols and the Use of Recombinant Activated Factor VII.

Louise E Phillips, BSc, (Hons), PhD, Cameron Willis, PhD, Amanda Zatta, PhD, Scott Dunkley, BMed(hons), FRACP, FRCPA, Peter Cameron, MD, MBBS, FACEM, Hatem H. Salem, MD, FRACP, FRCPA, James Isbister, MB, BS, BSc(MED), FRACP, FRCPA

Blood (2009) 114 (22): 4192.

https://doi.org/10.1182/blood.V114.22.4192.4192

Published: 2009

Journal Articles

Acquired Multiple Coagulation Factor Inhibitors Associated Bleeding Disorder

Qin-fen Chen, Pei Li, Yi Xie, Bao-An Chen

Blood (2008) 112 (11): 4511.

https://doi.org/10.1182/blood.V112.11.4511.4511

Published: 2008

Journal Articles

Clinical Outcomes of Off-Label Use of Recombinant Activated Factor VII (rFVIIa) at Teaching Hospitals Affiliated with a Medical School.

Yijun Cheng, MD, Melissa S. Baxter, PharmD, Walter S. Schroeder, PharmD, Zale P. Bernstein, MD

Blood (2006) 108 (11): 4033.

https://doi.org/10.1182/blood.V108.11.4033.4033

Published: 2006

Journal Articles

Increased Anti-Protein Z and Protein S Antibodies in Patients with Anti-Phospholipid Antibodies and/or Lupus Inhibitor.

Yale S. Arkel, MD, De-Hui W. Ku, PhD, Evelyn Y. Ku, Jeffrey Birnbaum, Xuam Lam, BS

Blood (2006) 108 (11): 4030.

https://doi.org/10.1182/blood.V108.11.4030.4030

Published: 2006

Journal Articles

The JAK2 Mutation V617F Is Specifically Associated with Idiopathic Splanchnic Vein Thrombosis.

Sandra Régina, MD, Olivier Herault, MD,PhD, Louis D’lteroche, MD, Yannick Bacq, MD, Jorge Domenenech, MD,PhD, Christian Binet, MD, Yves Gruel, MD

Blood (2006) 108 (11): 380.

https://doi.org/10.1182/blood.V108.11.380.380

Published: 2006

Journal Articles

Trombophylia Prevalence in 444 Patients with Clinical Suspicion of Thrombosis.

Joao Carlos C. Guerra, MD, Valdir F. Aranda, PhD, Claudio A. Mendes, PhD, Nelson Hamerschlak, MD, Nydia S. Bacal, MD, Marjorie P. Colombini, MD, Jacyr Pasternak, MD, Roberta Sitnik, Phd, Claudia H. Graca, Phd, Joao Renato R. Pinho, MD

Blood (2006) 108 (11): 4088.

https://doi.org/10.1182/blood.V108.11.4088.4088

Published: 2006

Journal Articles

Sequential Use of Recombinant Factor VIIa and FEIBA in a Pediatric Patient with Disseminated Intravascular Coagulation.

Paulette Bryant, MD, Theresa Sunderland, MD, Mark Mogul, MD

Blood (2006) 108 (11): 4066.

https://doi.org/10.1182/blood.V108.11.4066.4066

Published: 2006

Journal Articles

Coagulation Factor Activity in Therapeutic Plasma Prepared from Whole Blood with Pathogen Inactivation (INTERCEPT ™ ) Treatment.

Jean-Pierre Cazenave, Hervé Isola, Marie-Louise Wiesel, Daniel Kientz, Michel Laforêt, Linda Pinkoski, Yasmin Singh, Laurence Corash

Blood (2006) 108 (11): 4149.

https://doi.org/10.1182/blood.V108.11.4149.4149

Published: 2006

Journal Articles

Coagulation Factors in Therapeutic Apheresis Plasma Held for 18 Hours at Ambient Temperature Prior to Pathogen Inactivation (INTERCEPT™).

Jean-Pierre Cazenave, Hervé Isola, Marie-Louise Wiesel, Daniel Kientz, Michel Laforêt, Marc Slaedts, Linda Pinkoski, Yasmin Singh, Laurence Corash

Blood (2006) 108 (11): 940.

https://doi.org/10.1182/blood.V108.11.940.940

Published: 2006

Journal Articles

Evidence of Abnormal Coagulation: Production of Factor VIII α-Fragment In Vivo .

Pierre F. Neuenschwander, PhD, FAHA

Blood (2005) 106 (11): 1020.

https://doi.org/10.1182/blood.V106.11.1020.1020

Published: 2005

Journal Articles

Thrombin Generation Assay: Use in Monitoring Treatment of Patients with Coagulation Factor Inhibitors.

Aine N. McCormick, Ph.D., Peter L. Turecek, Ph.D., Katalin Varadi, Ph.D., Geoffrey F. Savidge

Blood (2004) 104 (11): 3087.

https://doi.org/10.1182/blood.V104.11.3087.3087

Published: 2004

Journal Articles

COAT Platelet Formation Is P2Y12-Dependent.

Christine L. Kempton, MD, Maureane Hoffman, MD, PhD, Angie Lenkowski, Harold R. Roberts, MD, Dougald M. Monroe, PhD

Blood (2004) 104 (11): 1569.

https://doi.org/10.1182/blood.V104.11.1569.1569

Published: 2004

Journal Articles

The Hemostatic State in Cancer Patients: The Relationship between Hypercoagulable Markers and Cancer Prognostic Markers.

Shaker A. Mousa, PhD, MBA, FACC, FACB, Hussain Alizadeh, MD, Shaikhah Al-Tajer, MD

Blood (2004) 104 (11): 4027.

https://doi.org/10.1182/blood.V104.11.4027.4027

Published: 2004

Journal Articles

Physiologic Inhibitors of Coagulation, Thrombophilic Acquired Factors and Venous Thromboembolism in Gastrointestinal Cancer Patients.

Gaia Schiavon, MD, Odoardo M. Olimpieri, MD, Barbara Giannetti, BSc, Maria C. Tirindelli, MD, Annalisa La Cesa, MD, Domenico Borzomati, MD, Bruno Vincenzi, MD, Roberto Coppola, MD, Giuseppe Tonini, MD, Giuseppe Avvisati, MD, PhD

Blood (2004) 104 (11): 4044.

https://doi.org/10.1182/blood.V104.11.4044.4044

Published: 2004

Journal Articles

Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study

Harry L. A. Janssen, Johan R. Meinardi, Frank P. Vleggaar, Stan H. M. van Uum, Elizabeth B. Haagsma, Felix J. M. van der Meer, Jan van Hattum, Robert A. F. M. Chamuleau, Rob P. Adang, Jan P. Vandenbroucke, Bart van Hoek, Frits R. Rosendaal

Blood (2000) 96 (7): 2364–2368.

https://doi.org/10.1182/blood.V96.7.2364

Published: 2000

NARROW

Clinical Outcomes of Acquired Factor VIII Inhibitors in Cancer Population: A Systematic Review

Characterization of an autosomal dominant bleeding disorder caused by a thrombomodulin mutation

Inherited Pro-Thrombotic Risk Factors in Children of South Moravia Region, Czech Republic

Barriers to the Effective Diagnosis and Management of a Bleeding Patient with Undiagnosed Bleeding Disorder Across Multiple Specialties: Results of a Quantitative Case-Based Survey.

Thrombophilia as a Risk Factor for Central Retinal Vein Thrombosis.

Adherence to Transfusion Protocols and the Use of Recombinant Activated Factor VII.

Acquired Multiple Coagulation Factor Inhibitors Associated Bleeding Disorder

Clinical Outcomes of Off-Label Use of Recombinant Activated Factor VII (rFVIIa) at Teaching Hospitals Affiliated with a Medical School.

Increased Anti-Protein Z and Protein S Antibodies in Patients with Anti-Phospholipid Antibodies and/or Lupus Inhibitor.

The JAK2 Mutation V617F Is Specifically Associated with Idiopathic Splanchnic Vein Thrombosis.

Trombophylia Prevalence in 444 Patients with Clinical Suspicion of Thrombosis.

Sequential Use of Recombinant Factor VIIa and FEIBA in a Pediatric Patient with Disseminated Intravascular Coagulation.

Coagulation Factor Activity in Therapeutic Plasma Prepared from Whole Blood with Pathogen Inactivation (INTERCEPT ™ ) Treatment.

Coagulation Factors in Therapeutic Apheresis Plasma Held for 18 Hours at Ambient Temperature Prior to Pathogen Inactivation (INTERCEPT™).

Evidence of Abnormal Coagulation: Production of Factor VIII α-Fragment In Vivo .

Thrombin Generation Assay: Use in Monitoring Treatment of Patients with Coagulation Factor Inhibitors.

COAT Platelet Formation Is P2Y12-Dependent.

The Hemostatic State in Cancer Patients: The Relationship between Hypercoagulable Markers and Cancer Prognostic Markers.

Physiologic Inhibitors of Coagulation, Thrombophilic Acquired Factors and Venous Thromboembolism in Gastrointestinal Cancer Patients.

Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only